Figure 1 (IMAGE)

Tohoku University

Figure 1

Caption

(A) Breakdown CGP by organ(s) of origin. (B) The percentage of patients with mutations that could not be matched with a relevant drug; The percentage of patients that obtained a subsequent treatment recommendation based on CGP; the percentage of patients who actually received the recommended next treatment; the percentage of patients who also received ctDNA monitoring in the present cohort. 

Credit

©Sasaki et al.

Usage Restrictions

Reporters may use freely these materials in news coverage with appropriate credit information.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.